stockrow
Saturday 7 November 2026
Export VANI’s income statement to Excel — free account
Vivani Medical, Inc.
VANI Healthcare Biotechnology
- EPS
- +41.7%
- Free cash flow
- +0.39%
Quarter to June 2026, against a year earlier
1.06
0.02
+1.92%
Follow VANI
Alert me
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
— | — | — | — |
+8 more quarters Free account |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
3.09 | 3.02 | 2.56 | 0.48 | |
Current Ratio |
3.25 | 3.18 | 2.71 | 0.61 | |
Net Debt/EBITDA |
2.95 | 2.95 | 2.42 | 0.40 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.95 | 0.91 | 1.01 | 0.97 | |
Capex/Depreciation |
(0.77) | (0.02) | (2.38) | (7.84) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.07) | (0.08) | (0.11) | (0.11) | |
Capex per Share |
0.00 | 0.00 | 0.00 | (0.01) | |
Free Cash Flow per Share |
(0.07) | (0.08) | (0.11) | (0.12) | |
Cash per Share |
0.23 | 0.24 | 0.26 | 0.04 | |
Shareholders Equity per Share |
0.22 | 0.23 | 0.25 | 0.02 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.22 | 0.23 | 0.25 | 0.02 | |
Free Cash Flow |
(6.13) | (6.20) | (6.99) | (7.17) | |
Working Capital |
14.98 | 14.77 | 11.30 | (2.65) | |
Capital Expenditures |
(0.10) | 0.00 | (0.27) | (0.82) | |
Net Current Asset Value |
(1.04) | (1.72) | (5.76) | (19.56) | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
0.60 | 0.44 | 0.45 | 0.43 | |
Average Payables |
1.48 | 1.23 | 0.92 | 1.12 | |
Average Assets |
35.27 | 38.90 | 40.48 | 33.97 | |
Average Common Equity |
11.94 | 15.35 | 16.67 | 9.82 |
Columns are period end dates